In clinical and experimental settings, GRK6 downregulation is associated with chronic inflammatory diseases such as rheumatoid arthritis, chronic inflammatory bowel disease and severe inflammatory response syndrome. This evidence concerns the gene GRK6 and rheumatoid arthritis.